newscontact us


Blood and Bone Marrow

CLIRST III Clinical Trial


Cesca’s SurgWerks Platform is a vision for the future of regenerative medicine that enables a complete therapy delivered at point of care. Our pipeline of therapies target vascular disease with an integrated system for the harvesting, processing and delivery of autologous stem cells to the patient in less than 2 hours.


The CellWerks Platform is a solution for intra-laboratory bioprocessing and analysis of blood cells for clinical applications. Based on our patented AutoXpress® technology, CellWerks delivers a functionally closed system for concentrating hematopoietic stem cells in under one hour.

Bone Marrow Transplant

Cesca’s Bone Marrow Program technology for bone marrow processing is designed rapid and efficient delivery of a stem cell concentrate from bone marrow for oncology applications according to local regulatory approval.

Video Library

January, 2016 interview with Cesca Therapeutics’ CEO Robin Stracey

Robin Stracey discusses the Company’s approach to regenerative medicine with autologous stem cells.

CLI Compassionate Use Video

Testimonials from patients and doctors who participated in stem cell-based regenerative therapy for critical limb ischemia.